JAK2 and hepatocellular carcinoma: The distribution of JAK2 mutation among idiopathic PVT cases with either HCC or liver cirrhosis was about 28/100 (28%), while secondary causes (cases with other thrombophilic risk factors) were found to be 72/100 (72%) (Table 2).